Recent Updates
Recently added Catalysts
IMDX Positive Sentiment

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

Wednesday, September 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Insight Molecular Diagnostics Inc. (IMDX) will participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference on September 10, 2026. CEO Josh Riggs and CFO Andrea James will represent the company in one-on-one meetings with investors at the Metropolitan Club in New York City. This event aims to enhance investor engagement and showcase the company's innovative diagnostics technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a reputable conference enhances visibility.
  • Opportunity for one-on-one meetings with investors.
  • Leadership presence indicates confidence in company direction.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~5 mo
High dilution risk
Lead asset
99mTc-MIP-1404
Phase 3 · Prostate Cancer

Full Press Release Details

NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10 th Annual Best Ideas Growth “BIG10” Conference taking place September 10 th, 2026 in New York.
Event: Lake Street Capital Markets 10 th Annual Best Ideas Growth “BIG10” Conference Who: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James Date: Thursday, September 10, 2026 Location: Metropolitan Club, New York City Format: One-on-one meetings Investors wishing to meet with IMDX management are encouraged to reach out to their Lake Street sales representative.
About Insight Molecular Diagnostics Inc. Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.
GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact: Alexandra Grossman LifeSci Advisors LLC imdx@lifesciadvisors.com

Frequently Asked Questions

When is the Lake Street BIG10 Conference?

The conference is scheduled for September 10, 2026.

Who will represent iMDx at the conference?

CEO Josh Riggs and CFO Andrea James will represent iMDx.

Where will the conference be held?

The conference will take place at the Metropolitan Club in New York City.

What is the format of the conference?

The format includes one-on-one meetings with investors.

ShareAdd on Google
Tags: IMDX Viatris Investor Conferences Healthcare iMDx Lake Street Conference investor meetings molecular diagnostics Josh Riggs
Last updated: Sep 2, 2026

Biotech snapshot

Cash runway
$18M liquidity · $3M/mo burn
~5 mo
High dilution risk
Lead asset
99mTc-MIP-1404Phase 3
Prostate Cancer →